Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

NCT00700882 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: dasatinib

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]